Managing Class II Obesity with Prediabetes & OSA

📋 HISTORY

• 35-year-old female
• Prediabetes confirmed
• Normotensive
• Back pain
• Ankle sprain
• Obstructive Sleep Apnea (OSA)

🩺 EXAMINATION

• BMI: 38.9 kg/m²
• Blood pressure: Normal
• Back pain noted
• Ankle sprain present

🔬 INVESTIGATIONS

• HbA1c / Fasting Glucose → Prediabetes confirmed
• Sleep Study → OSA confirmed
• BMI Calculation → 38.9 kg/m²

❓ MCQ QUESTIONS

Q1. According to WHO, how is this patient's obesity classified?

A. Class 1 (BMI 30–34.9)
B. Class 2 (BMI 35–39.9)
C. Class 3 (BMI ≥40)
D. Overweight (BMI 25–29.9)

Q2. Which of the following is NOT a recommended management option?

A. Lifestyle advice
B. Weight-loss diet
C. Bariatric surgery
D. High-dose corticosteroids

Q3. Which drug is approved for obesity management and benefits prediabetes?

A. Orlistat
B. Naltrexone/Bupropion
C. Tirzepatide
D. Topiramate/Phentermine

📝 BRIEF CASE SUMMARY

35-year-old woman with severe obesity, prediabetes, and obstructive sleep apnea presents with obesity-related musculoskeletal complications including back pain and ankle sprain. Appropriate obesity classification and management are required.

✅ CLICKABLE ANSWERS

Show Answers

Q1: B. Class 2 Obesity

Q2: D. High-dose corticosteroids

Q3: C. Tirzepatide (GIP/GLP-1 agonist)

📖 ANSWER EXPLANATION

• BMI 38.9 kg/m² falls within WHO Class 2 Obesity (35–39.9).
• Corticosteroids promote weight gain and worsen insulin resistance.
• Tirzepatide significantly reduces weight and improves glycemic status.

❌ WHY NOT OTHERS?

• Class 1: BMI below 35.
• Class 3: Requires BMI ≥40.
• Overweight: BMI 25–29.9.
• Orlistat: Less weight reduction.
• Naltrexone/Bupropion: Useful but less metabolic benefit.
• Topiramate/Phentermine: Effective but not preferred here.

📚 5 BRIEF CASE SCENARIOS

• BMI 32 with hypertension → Class 1 obesity.
• BMI 37 with NAFLD → Class 2 obesity.
• BMI 43 with diabetes → Class 3 obesity.
• OSA with BMI 36 → Candidate for intensive weight loss.
• Prediabetes + severe obesity → GLP-1/GIP agonist considered.

🧬 PATHOPHYSIOLOGY SIMPLIFIED

• Excess calorie intake → Fat accumulation.
• Adipose tissue releases inflammatory mediators.
• Insulin resistance develops.
• Prediabetes occurs.
• Mechanical overload causes back and joint pain.
• Upper airway narrowing contributes to OSA.

🩺 PHYSICAL EXAMINATION PEARLS

• Calculate BMI for every patient.
• Measure waist circumference.
• Assess BP regularly.
• Screen for OSA symptoms.
• Look for acanthosis nigricans.
• Assess gait and mobility limitations.

🔎 INVESTIGATIONS: CHOOSING WISELY

• HbA1c
• Fasting glucose
• Lipid profile
• Liver function tests
• Sleep study if OSA suspected
• TSH if clinically indicated

💊 MANAGEMENT

• Calorie-restricted diet
• Exercise prescription
• Behavioral therapy
• Tirzepatide or approved anti-obesity medication
• OSA treatment
• Bariatric surgery when indicated

🔄 DIFFERENTIAL DIAGNOSIS

• Hypothyroidism
• Cushing syndrome
• PCOS
• Medication-induced obesity
• Depression-related weight gain

⚠️ CLINICAL PITFALLS

• Ignoring OSA screening
• Missing prediabetes
• Failure to assess cardiovascular risk
• Not considering bariatric surgery
• Unrealistic weight-loss expectations

💎 CLINICAL PEARLS

• 5–10% weight loss improves outcomes.
• OSA improves with weight reduction.
• Prediabetes can revert to normoglycemia.
• BMI and comorbidities guide therapy.
• Multidisciplinary management works best.

📅 MONITORING & FOLLOW-UP

• Weight every visit
• BMI every visit
• HbA1c every 3–6 months
• OSA symptom review
• Medication side effects
• Diet and exercise adherence

❔FAQ

1. What BMI defines obesity? BMI ≥30 kg/m².
2. What BMI defines Class 2 obesity? 35–39.9 kg/m².
3. Why does obesity cause OSA? Airway narrowing from fat deposition.
4. What is prediabetes? Intermediate hyperglycemia.
5. First-line obesity treatment? Lifestyle modification.
6. Importance of BMI? Risk assessment.
7. Best dietary strategy? Calorie deficit.
8. Can obesity cause back pain? Yes.
9. Can obesity affect joints? Yes.
10. When use anti-obesity drugs? BMI ≥30 or ≥27 with comorbidity.
11. When consider bariatric surgery? Severe obesity meeting criteria.
12. What is Tirzepatide? GIP/GLP-1 agonist.
13. Can prediabetes improve? Yes.
14. How much weight loss is beneficial? 5–10% minimum.
15. Follow-up frequency? Every 1–3 months initially.

📚 KEY GUIDELINES & REFERENCES

• WHO Obesity Classification
• ADA Standards of Care
• AACE Obesity Guidelines
• Endocrine Society Guidelines
• ASMBS Bariatric Surgery Guidelines

🔑 KEYWORDS

Obesity Classification Class 2 Obesity BMI 38.9 Prediabetes OSA Tirzepatide Obesity Management Bariatric Surgery Internal Medicine Quiz WHO BMI Classification

📘 INTERNAL MEDICINE QUIZ FACEBOOK

Visit Internal Medicine Quiz Facebook Page

🔗 Explore More Topics:

🫀 Cardiology 🫁 Respiratory 🧠 Neurology 🩸 Hematology 🧪 Nephrology 🦠 Gastroenterology 🏥 Hepatology 🦴 Rheumatology 💉 Endocrinology 🩺 ABG 🧩 Psychiatry ☠️ Poisoning 🌿 Environment

🏠 Back to Home  |  📬 Contact Us  |  📋 About Us